Pinney & Scofield’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$152K Hold
5,321
– – 0.07% 76
2026
Q2
$128K Hold
5,321
– – 0.06% 71
2026
Q1
$149K Hold
5,321
– – 0.08% 65
2025
Q4
$132K Hold
5,321
– – 0.08% 64
2025
Q3
$136K Hold
5,321
– – 0.08% 59
2025
Q2
$129K Hold
5,321
– – 0.09% 65
2025
Q1
$135K Hold
5,321
– – 0.1% 61
2024
Q4
$141K Buy
+5,321
New +$144K 0.11% 59

Other funds holding PFE

Pinney & Scofield's PFE Position: Q3 2026 in Review

Pinney & Scofield held its Pfizer (PFE) position steady in Q3 2026 at 5,321 shares worth $152K. The position accounts for 0.07% of the portfolio, ranked #76.

Pinney & Scofield first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 2,907 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Pinney & Scofield held 5,321 shares of Pfizer worth $152K as of Q3 2026.
  • Pinney & Scofield left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.07% of Pinney & Scofield's portfolio in Q3 2026, its #76 holding.
  • Pinney & Scofield first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 2,907 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Pinney & Scofield's 13F filing for Q3 2026, filed 12 Nov 2026.